Randomized Controlled Trial Comparing Single Port Simple Prostatectomy and Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia

What this Trial Is About

This research aims to compare two surgical treatments for benign prostatic hyperplasia (BPH) in men who experience lower urinary tract symptoms or bladder outlet obstruction after non-surgical treatments have not worked. The trial evaluates the outcomes of a newer single port robotic simple prostatectomy using the da Vinci platform against thulium laser enucleation of the prostate. Both procedures are recommended for larger prostate sizes and are performed to address urinary symptoms related to BPH. Participants will be randomly assigned to receive either the single port robotic prostatectomy, which removes the whole prostate through a small incision using robotic assistance, or laser enucleation, which removes prostate tissue using laser technology while preserving the prostate capsule. This study will measure surgical parameters like operative time, blood loss, and hospital stay, as well as post-surgical complications and urinary function outcomes. The trial also assesses quality of life and sexual health before and seven months after surgery. During the study, participants will undergo evaluations including questionnaires about urinary symptoms, sexual health, and quality of life, as well as tests measuring urinary flow rate and residual urine volume. Researchers will track surgical complications and any incidental findings of cancer. The trial's findings aim to help guide patients and doctors in choosing the best surgical option for BPH. The total participation duration includes assessments before and seven months after the procedure, with monitoring during and immediately after surgery.

Prostate Single Port & Laser Enucleation Comparison Trial